Goldman Sachs

Activity in this selectionjefferson-life-sciences-dd9e1469

By stage

Series C+3

Biotech1

Climate tech1

Fintech1

United States3

3 in this selection

Jun 17

Develops novel antibody treatments for immunological and inflammatory disorders

$65MSeries C

Role not disclosed

Mar 19

Provides a proprietary technology and turnkey asset management platform for registered investment advisors

$42.5MSeries C

Role not disclosed

Jan 28

Recycles batteries and produces cathode materials for energy storage

$425MSeries E

Role not disclosed